Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | LDHB | P07195 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14690127 | 1.00 | CA1 (0.36) | CA1CA2CA9LDHALDHB | |
| SCHEMBL988834 | 1.00 | CA1 (0.36) | CA1CA2CA9LDHALDHB | |
| SCHEMBL9156417 | 0.95 | LDHA (0.33) | CA1CA2CA9LDHALDHB | |
| SCHEMBL9156418 | 0.95 | LDHA (0.33) | CA1CA2CA9LDHALDHB | |
| Boric Acid SCHEMBL31404421 | 0.88 | LMNA (0.31) | — | |
| Boric Acid SCHEMBL31404443 | 0.88 | LMNA (0.31) | — | |
| SCHEMBL132786 | 0.82 | — | — | |
| SCHEMBL11129009 | 0.82 | LDHA (0.50) | LDHALDHBGABRR1ACHE | |
| SCHEMBL15546673 | 0.79 | — | — | |
| SCHEMBL15547842 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115053381-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-115053380-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-115023843-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-115023844-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114868298-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114846654-A | Method for precipitating a polymer | 广东省皓智科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114503336-A | Method for stripping composite | 广东省皓智科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114424365-A | Cathode for secondary battery and cathode slurry | 广东省皓智科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-114341304-A | Binder composition for secondary battery | 广东省皓智科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114342124-A | Binder composition for secondary battery | 广东省皓智科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-2184059-B1 | Potassium-binding polymers for use in a therapeutic or prophylactic method for treating hyperkalemia | RELYPSA INC (US) | 2012-06-27 | — | — | EP | claimed |
| EP-1732523-B9 | POTASSIUM BINDING POLYMERS AND USES THEREOF | RELYPSA INC (US) | 2010-06-02 | — | — | EP | claimed |
| EP-2184059-A2 | Ion binding polymers and uses thereof | Relypsa, Inc. (US) | 2010-05-12 | — | — | EP | claimed |
| EP-1732523-B1 | POTASSIUM BINDING POLYMERS AND USES THEREOF | RELYPSA INC (US) | 2010-03-17 | — | — | EP | claimed |
| US-7556799-B2 | Ion binding polymers and uses thereof | RELYPSA, INC. (US) | 2009-07-07 | — | — | US | claimed |
| US-7488495-B2 | Ion binding polymers and uses thereof | RELYPSA, INC. (US) | 2009-02-10 | — | — | US | claimed |
| EP-1732523-A4 | ION BINDING POLYMERS AND USES THEREOF | ILYPSA INC (US) | 2007-06-06 | — | — | EP | claimed |
| EP-1732523-A1 | ION BINDING POLYMERS AND USES THEREOF | Ilypsa, Inc. (US) | 2006-12-20 | — | — | EP | claimed |
| WO-2005097081-A1 | ION BINDING POLYMERS AND USES THEREOF | ILYPSA, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| US-20050220751-A1 | Ion binding polymers and uses thereof | VIFOR (INTERNATIONAL) LTD. (CH) | 2005-10-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050220751-A1 | Ion binding polymers and uses thereof | ATP6V1B1, KCNN3, SLC9A3 | CA1 426/4885CA2 47/4885CA9 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.